AC Immune (ACIU)
Develops protein-misfolding therapies and diagnostics for neurodegenerative diseases.
$2.73
After hours−0.01 (−0.36%)
At close$2.74(+3.20%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
estimated · in 42 days
EPS estimate
−$0.22
Revenue estimate
$243.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported−$0.18−$0.21−$0.25−$0.20−$0.18−$0.19$0.03Pending
Estimate−$0.21−$0.22−$0.20−$0.22−$0.19−$0.20−$0.10−$0.22
Surprise+14.3%+4.5%−25.0%+9.1%+5.3%+5.0%+128.7%—
RevenueReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported$1.3M$1.2M$1.6M$1.2M$428.9K$1.4M$15.2MPending
Estimate$819.5K$473.7K$315.8K$1.1M$1.4M$329.4K$9.6M$243.0K
Surprise+52.8%+145.4%+420.5%+3.2%−70.3%+325.0%+58.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.10 | — | — |
| Nov 2026 | −$0.22 | — | — |
| Aug 2026 | −$0.10 | $0.03 | +128.7% |
| Apr 2026 | −$0.20 | −$0.19 | +5.0% |
| Mar 2026 | −$0.19 | −$0.18 | +5.3% |
| Nov 2025 | −$0.22 | −$0.20 | +9.1% |
| Aug 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Apr 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Jun 2016 | |||
| Sep 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.10 | — | — | $7.4M | — | — | — |
| Nov 3, 2026 | −$0.22 | — | — | $243.0K | — | — | — |
| Aug 5, 2026 | −$0.10 | $0.03 | +128.7% | $9.6M | $15.2M | +58.2% | +0.9% |
| Apr 30, 2026 | −$0.20 | −$0.19 | +5.0% | $329.4K | $1.4M | +325.0% | +3.4% |
| Mar 13, 2026 | −$0.19 | −$0.18 | +5.3% | $1.4M | $428.9K | −70.3% | +0.7% |
| Nov 4, 2025 | −$0.22 | −$0.20 | +9.1% | $1.1M | $1.2M | +3.2% | +3.8% |
| Aug 5, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 4, 2023 | |||||||
| Apr 28, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Oct 28, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Mar 22, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 4, 2021 | |||||||
| Apr 28, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 13, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 4, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 21, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 2, 2018 | |||||||
| Mar 20, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 17, 2017 | |||||||
| Nov 11, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Sep 23, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |